Jesper K.

The DrugStars ecosystem comprises the scientifically validated DrugStars medication app, the DrugsDisclosed.com our SaaS platform for patients, pharmaceutical companies and payers alike. DrugsDisclosed.com is a free service for patients, patient associations and authorities to access over three million medication experiences from real-world patients. DrugsDisclosed.com collates data from 430,000 patient reviews from global users of the DrugStars medication app, launched by Claus Møldrup in 2017. The service has over 55 million unique data points around medication reviews. It provides anonymous secondary market patient insights for specific medications and conditions. DrugStars is committed to empowering patients. The company donates 20% of its revenues to over 240 global patient organizations and enables the users to earn donations for their chosen organization. To date, DrugStars has donated £376,835 to patient organisations around the world.

The DrugStars ecosystem comprises the scientifically validated DrugStars medication app, the DrugsDisclosed.com our SaaS platform for patients, pharmaceutical companies and payers alike. DrugsDisclosed.com is a free service for patients, patient associations and authorities to access over three million medication experiences from real-world patients. DrugsDisclosed.com collates data from 430,000 patient reviews from global users of the DrugStars medication app, launched by Claus Møldrup in 2017. The service has over 55 million unique data points around medication reviews. It provides anonymous secondary market patient insights for specific medications and conditions. DrugStars is committed to empowering patients. The company donates 20% of its revenues to over 240 global patient organizations and enables the users to earn donations for their chosen organization. To date, DrugStars has donated £376,835 to patient organisations around the world.

BBHS is closing the last gap in airport baggage handling automation. Differs from all other existing solutions in the market, BBHS provides the ultimate simple and innovative automated baggage handling between terminal and aircraft. The 60% improved footprint utilization, easy integration with baggage tracking capability, highly efficient which reduces turnaround time and the flexible nature of the BBHS solutions can be integrated in all existing Baggage Handling System of all airports. BBHS is an empowering ergonomic work tool for baggage handlers. It provides support, so baggage handlers can do their job safely, and productively, which in turn boosts job satisfaction, retention and reduce injury in relation to manual handling processes which is a frequent concern of Occupational health and safety issues (OH&S). Based on its documented results at Danish Billund Airport https://youtu.be/kCXNAp7Nlko BBHS has won multiple international innovation awards. BBHS is a subsidiary of Danish joint holding company CPHI-Holding A/S https://www.cphi-holding.com/ . CPHI-Holding A/S consists of three main business segments operating with single focus to push operational and financial boundaries within aviation. Other subsidiaries: Exruptive A/S http://www.exruptive.com/, the next generation CT X-ray scanning for cabin baggage security screening, Intelligent Track Systems ITS http://www.intelligenttracksystems.com/ - Intelligent Trolley Service, the personal guide to a stress free airport experience, keeping passenger with flight/gate info and the latest retail offers.

We turn composite waste into recyclable building materials. It’s a win-win-win: Industries like wind power produce thousands of tons of composite waste every year. A issue that they are still struggling to deal with sustainably. At the same time the construction industry is challenged: They need to start utilising new, more circular building components with lower CO2 footprints. With Continuums advanced mechanical technology, we can turn composite waste into recyclable products for buildings. It’s a win for composite industries. It’s a win for construction. And definitely a huge win for the planet.

"Attavik"​ is Greenlandic for connection and was founded from Greenland. Attavik A/S is a startup with a vision to connect the unconnected using an ad-hoc mesh/peer2peer network of own design. As of late 2017 we are building a proof of concept enabling communication over longer distances.

The DrugStars ecosystem comprises the scientifically validated DrugStars medication app, the DrugsDisclosed.com our SaaS platform for patients, pharmaceutical companies and payers alike. DrugsDisclosed.com is a free service for patients, patient associations and authorities to access over three million medication experiences from real-world patients. DrugsDisclosed.com collates data from 430,000 patient reviews from global users of the DrugStars medication app, launched by Claus Møldrup in 2017. The service has over 55 million unique data points around medication reviews. It provides anonymous secondary market patient insights for specific medications and conditions. DrugStars is committed to empowering patients. The company donates 20% of its revenues to over 240 global patient organizations and enables the users to earn donations for their chosen organization. To date, DrugStars has donated £376,835 to patient organisations around the world.

ASNET Board is the largest Danish network organisation for board members. We offer a place where board members and future board members can grow their career as external board members. We do so through network, seminars, knowledge sharing and so on. ASNET Board supports Danish SME companies in establishing an external board of directors and in this way strengthen the companies​ management. We believe that a board of directors should exist only with the purpose of strengthening and developing the company. Our mission is - To generate progress and results in small and medium sized companies - To be an active and developing network for board members If you want to hear more about ASNET Board, please contact us here: https://asnet.dk/kontakt/

The DrugStars ecosystem comprises the scientifically validated DrugStars medication app, the DrugsDisclosed.com our SaaS platform for patients, pharmaceutical companies and payers alike. DrugsDisclosed.com is a free service for patients, patient associations and authorities to access over three million medication experiences from real-world patients. DrugsDisclosed.com collates data from 430,000 patient reviews from global users of the DrugStars medication app, launched by Claus Møldrup in 2017. The service has over 55 million unique data points around medication reviews. It provides anonymous secondary market patient insights for specific medications and conditions. DrugStars is committed to empowering patients. The company donates 20% of its revenues to over 240 global patient organizations and enables the users to earn donations for their chosen organization. To date, DrugStars has donated £376,835 to patient organisations around the world.